Processa Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity Disclosure: Schedule of Stock Option Activity (Tables)

12 Months Ended

Dec. 31, 2015

	Number of Options	Weighted Average Exercise Price	Weighted Average Remaining Life (Years)
Balance, December 31, 2013	1,320,000	$ 2.23	3.44
Granted	298,000	$ 3.00
Exercised	-	-
Cancelled	(371,500)	$ 2.46
Balance, December 31, 2014	1,246,500	$ 2.35	2.83
Exercisable, December 31, 2014	882,583	$ 2.20	2.52
Granted	425,000	$ 1.50
Exercised	-	-
Cancelled	(1,080,333)	$ 2.33
Balance, December 31, 2015	591,167	$ 1.78	3.75
Exercisable, December 31, 2015	463,000	$ 1.76	3.68